• LAST PRICE
    3.4200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    3.4000/ 3
  • Ask / Lots
    3.4700/ 5
  • Open / Previous Close
    3.3300 / 3.4200
  • Day Range
    Low 3.3101
    High 3.4800
  • 52 Week Range
    Low 2.6800
    High 8.2212
  • Volume
    142,323
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 3.34
TimeVolumeCAPR
09:32 ET3963.33
09:51 ET4003.35
09:55 ET1003.35
09:57 ET2503.3322
10:00 ET17923.34
10:04 ET1003.35
10:06 ET1003.35
10:08 ET1003.35
10:18 ET1003.44
10:22 ET3003.48
10:24 ET52963.44
10:26 ET3003.44
10:27 ET10003.35
10:29 ET31333.3101
10:31 ET8103.44
10:33 ET50003.38
10:36 ET6843.405
10:38 ET1003.405
10:40 ET5003.4223
10:49 ET2003.42
10:54 ET2003.42
10:58 ET114003.365
11:02 ET1003.38
11:09 ET1003.4
11:12 ET1003.4
11:14 ET1003.38
11:16 ET1933.36
11:18 ET1003.38
11:21 ET1003.35
11:23 ET5003.38
11:25 ET105163.42
11:27 ET1003.44
11:39 ET1653.44
11:41 ET3003.435
11:43 ET3003.435
11:48 ET1003.46
11:50 ET2003.44
11:54 ET89593.44
11:56 ET3003.44
11:57 ET1003.44
11:59 ET1003.44
12:06 ET2003.44
12:10 ET1003.44
12:12 ET1003.44
12:14 ET1003.44
12:19 ET3003.45
12:21 ET2503.4496
12:26 ET1203.44
12:28 ET1003.44
12:30 ET1003.44
12:33 ET2003.46
12:35 ET1003.45
12:37 ET34203.4101
12:44 ET1003.435
12:46 ET10003.4336
12:50 ET31003.46
12:55 ET4003.46
12:57 ET1003.46
01:00 ET2003.4319
01:02 ET1003.46
01:04 ET4003.44
01:06 ET1003.44
01:08 ET1003.44
01:11 ET8003.46
01:13 ET2603.42
01:15 ET108003.43
01:20 ET3003.425
01:27 ET1003.44
01:29 ET54003.41
01:31 ET5003.43
01:33 ET7003.44
01:36 ET1003.44
01:38 ET1003.44
01:44 ET1003.44
01:45 ET11003.44
01:47 ET1053.44
01:51 ET36053.42
01:54 ET29003.41
01:56 ET1003.41
01:58 ET1003.41
02:00 ET43003.38
02:02 ET4213.39
02:03 ET12693.36
02:07 ET59843.399
02:12 ET1003.41
02:14 ET13123.42
02:16 ET6003.4225
02:18 ET1003.4225
02:23 ET1003.45
02:25 ET10003.4275
02:27 ET2003.45
02:30 ET1003.425
02:32 ET6073.42
02:38 ET31963.42
02:39 ET1003.425
02:41 ET1003.425
02:43 ET1003.425
02:50 ET12903.4
02:52 ET5003.4225
02:54 ET2003.425
03:03 ET2003.42
03:06 ET1003.4225
03:10 ET48003.401
03:14 ET1003.42
03:15 ET1003.42
03:26 ET2003.41
03:28 ET1003.43
03:33 ET1003.43
03:35 ET4003.42
03:37 ET1003.42
03:39 ET1003.42
03:42 ET1003.42
03:44 ET9293.42
03:46 ET5003.42
03:50 ET1003.42
03:51 ET4003.42
03:53 ET8003.41
03:55 ET8553.42
04:00 ET15943.42
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCAPR
Capricor Therapeutics Inc
102.8M
-3.0x
---
United StatesTGRP
Nanopharmaceutics Inc
105.8M
-181.0x
---
United StatesSTTK
Shattuck Labs Inc
101.5M
-1.1x
---
United StatesRVPH
Reviva Pharmaceuticals Holdings, Inc.
102.7M
-2.5x
---
United StatesBTAI
BioXcel Therapeutics Inc
104.5M
-0.5x
---
United StatesKNTE
Kinnate Biopharma Inc
102.7M
-0.8x
---
As of 2023-12-08

Company Information

Capricor Therapeutics, Inc. is a biotechnology company. The Company is focused on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of muscular and other select diseases. The Company’s lead candidate, CAP-1002, is an allogeneic cardiac-derived cell therapy that is in late-stage clinical development for treating Duchenne muscular dystrophy (DMD). CAP-1002 is designed to slow disease progression in DMD through the immunomodulatory, anti-inflammatory, and anti-fibrotic actions of cardiosphere-derived cells (CDCs), which are mediated by secreted exosomes laden with bioactive cargo. CAP-2003 is the name of its exosomes product candidate, which is derived from its CDCs. It is also developing its exosome technology as a therapeutic platform. The Company’s focus is on developing exosomes capable of delivering nucleic acids, including messenger RNA (mRNA), as well as proteins to treat or prevent a variety of diseases.

Contact Information

Headquarters
8840 Wilshire Blvd, 2nd FloorBEVERLY HILLS, CA, United States 90211
Phone
310-358-3200
Fax
302-655-5049

Executives

Executive Chairman of the Board
Frank Litvack
President, Chief Executive Officer, Director
Linda Marban
Chief Financial Officer
Anthony Bergmann
Executive Vice President, General Counsel
Karen Krasney
Director
Paul Auwaerter

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$102.8M
Revenue (TTM)
$14.0M
Shares Outstanding
30.8M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
3.84
EPS
$-1.15
Book Value
$0.47
P/E Ratio
-3.0x
Price/Sales (TTM)
7.3
Price/Cash Flow (TTM)
---
Operating Margin
-219.67%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.